EUVIMEDEUVIMED entdecken
Open Access

The OprF porin as a potential target for the restoration of carbapenem susceptibility in Pseudomonas aeruginosa expressing acquired carbapenemases

Patrice Nordmann iD, Nicolas Helsens iD, Laurent Poirel iD, Mustafa Sadek iD, Dirk Bumann, Jacqueline Findlay iD

Antimicrobial Agents and Chemotherapy · 2024

DOI: 10.1128/aac.00761-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Patrice Nordmann und 5 weiteren Autor:innen. Beteiligte Einrichtung: European Institute for Emerging Antibiotic Resistance, Pasteur Institute, Lille, France. Hauptthemen laut MEDLINE: Pseudomonas aeruginosa, Porins, beta-Lactamases, Microbial Sensitivity Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenem resistance in Pseudomonas aeruginosa is primarily due to the acquisition of carbapenemases and is often associated with a diminution of the membrane permeability. The outer membrane protein, OprD, is a well-known route, by which carbapenems, predominantly imipenem, can enter the cell, and its loss has been associated with reduced susceptibility to imipenem. In this study, we investigated the antibiotic susceptibility patterns of isogenic P. aeruginosa mutants containing various acquired β-lactamases, including carbapenemases, in a porin-depleted background. We identified that the deletion of oprF was associated with some recovery of susceptibility to carbapenems.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pseudomonas aeruginosaPorinsbeta-LactamasesMicrobial Sensitivity TestsBacterial ProteinsAnti-Bacterial AgentsCarbapenemsImipenem

Stichwörter der Autor:innen

OprDOprFPseudomonas aeruginosaantibiotic resistancecarbapenemsporins

Substanzen

Porinsbeta-LactamasesBacterial ProteinsAnti-Bacterial AgentscarbapenemaseCarbapenemsImipenemOprF protein, Pseudomonas aeruginosaOprD protein, Pseudomonas aeruginosa

Autor:innen und Institutionen

  • European Institute for Emerging Antibiotic Resistance, Pasteur Institute, Lille, France.
  • European Institute for Emerging Antibiotic Resistance, University of Fribourg, Fribourg, Switzerland.
  • Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
  • Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
  • Clinical Microbiology Unit, Pasteur Institute of Lille, Lille, France.
  • Biozentrum, University of Basel, Basel, Switzerland.

ORCID-Profile: Patrice Nordmann, Nicolas Helsens, Laurent Poirel, Mustafa Sadek, Jacqueline Findlay

Zitieren

APA

Nordmann, P., Helsens, N., Poirel, L., Sadek, M., Bumann, D., & Findlay, J. (2024). The OprF porin as a potential target for the restoration of carbapenem susceptibility in Pseudomonas aeruginosa expressing acquired carbapenemases. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00761-24

Vancouver

Nordmann P, Helsens N, Poirel L, Sadek M, Bumann D, Findlay J. The OprF porin as a potential target for the restoration of carbapenem susceptibility in Pseudomonas aeruginosa expressing acquired carbapenemases. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00761-24

BibTeX
@article{Nordmann2024,
  author = {Nordmann, Patrice and Helsens, Nicolas and Poirel, Laurent and Sadek, Mustafa and Bumann, Dirk and Findlay, Jacqueline},
  title = {The OprF porin as a potential target for the restoration of carbapenem susceptibility in Pseudomonas aeruginosa expressing acquired carbapenemases},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2024},
  doi = {10.1128/aac.00761-24}
}
Kostenlos starten →